首页> 外文期刊>Medical Molecular Morphology >KL-6 is another useful marker in assessing a micropapillary pattern in carcinomas of the breast and urinary bladder, but not the colon
【24h】

KL-6 is another useful marker in assessing a micropapillary pattern in carcinomas of the breast and urinary bladder, but not the colon

机译:KL-6是评估乳腺癌和膀胱癌而非结肠癌微乳头型的另一种有用标记

获取原文
获取原文并翻译 | 示例
           

摘要

To evaluate the peculiar "inside-out" pattern in micropapillary (MP) carcinoma, we investigated the usefulness of KL-6 antibody in the assessment of the MP pattern of cancers, in comparison with antibodies to epithelial membrane antigen (EMA), MUC1 (CD227), and CD 10. Immunohistochemical investigation was performed on specimens exhibiting an MP pattern obtained from 12 persons with cancer: 4 with breast carcinoma, 3 with carcinoma of the urinary bladder, and 5 with colonic carcinoma. Immunohistochemical study with KL-6, EMA, and MUC1 antibodies revealed similar continuous linear positive patterns restricted to the surface of the MP pattern in both breast and urinary bladder cancers, revealing the peculiar "inside-out" morphology. However, EMA also gave cyto-plasmic positivity in most of the cases tested, and MYC1 was also present in the cytoplasm of some cases. In sharp contrast, immune reactions of colon carcinomas with these antibodies were negative, except for focal positivity for KL-6 and MUC1 antibodies in some cases. CD10 was only focally positive in an MP pattern in 4 of the 5 cases of colon carcinoma and in 1 case with carcinoma of the urinary bladder. These findings suggest that KL-6 is a useful marker to assess the MP character of breast and urinary bladder carcinomas; that MUC1 was similarly positive, with thernaddition of cytoplasmic positivity in some cases; and that the MP pattern of colon cancer, positive for CD 10, was different in character from both breast and urinary bladder carcinomas, although all these cancers seemingly exhibit similar MP patterns on histopathology. This heterogeneity of the MP pattern in various cancers needs to be investigated when more cases have been accumulated.
机译:为了评估微乳头状(MP)癌中特有的“由内而外”模式,我们将KL-6抗体与上皮膜抗原(EMA)MUC1抗体进行了比较,以评估癌症的MP模式。 CD227)和CD10。对表现出MP模式的标本进行了免疫组织化学研究,该标本来自12名癌症患者:4名乳腺癌,3名膀胱癌和5名结肠癌。用KL-6,EMA和MUC1抗体进行的免疫组织化学研究显示,在乳腺癌和膀胱癌中,相似的连续线性阳性模式仅限于MP模式的表面,从而揭示了独特的“由内而外”形态。但是,在大多数测试的病例中,EMA也可提供细胞质阳性,在某些情况下,MYC1也存在于细胞质中。与之形成鲜明对比的是,除了在某些情况下对KL-6和MUC1抗体的局灶性阳性外,结肠癌与这些抗体的免疫反应均为阴性。 CD10仅在5例结肠癌中的4例和1例膀胱癌的MP模式下呈局灶性阳性。这些发现表明,KL-6是评估乳腺癌和膀胱癌的MP特征的有用标志物。 MUC1同样是阳性的,在某些情况下增加了细胞质的阳性率;且CD 10阳性的结肠癌的MP模式与乳腺癌和膀胱癌的特征不同,尽管所有这些癌在组织病理学上似乎都表现出相似的MP模式。当累积更多病例时,需要研究MP模式在各种癌症中的异质性。

著录项

  • 来源
    《Medical Molecular Morphology》 |2009年第2期|123-127|共5页
  • 作者单位

    Division of Pathology, Matsuyama-shimin Hospital, Matsuyama, Ehime 790-0067, Japan;

    Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan;

    Department of Surgery, Matsuyama-shimin Hospital, Matsuyama,Ehime, Japan;

    Department of Surgery, Matsuyama-shimin Hospital, Matsuyama,Ehime, Japan;

    Department of Urology, Matsuyama-shimin Hospital, Matsuyama, Ehime, Japan;

    Division of Pathology, Matsuyama-shimin Hospital, Matsuyama, Ehime 790-0067, Japan;

    Department of Pathology, Kochi Medical School, Kochi University, Kochi, Japan;

    Department of Pathology, Kochi Medical School, Kochi University, Kochi, Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    KL-6; EMA; MUC1; CD10; micropapillary carcinoma; immunohistochemistry;

    机译:KL-6;EMA;MUC1;CD10;微乳头状癌免疫组化;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号